Security Television Network
Award notice: Olopatadine HCL 0.1% Ophthalmic Solution
SAM.gov award notice: Olopatadine HCL 0.1% Ophthalmic Solution. Read the original notice, agency, solicitation and source dates. STN does not infer a winning company or award amount.
Record details
- Name
- Olopatadine HCL 0.1% Ophthalmic Solution
- Published
- 2026-01-27
- Record modified
- 2026-10-08T19:34:51.338Z
- Record type
- Award notice
- SAM.gov notice ID
- 172ef8534f7745e6b7958d9ad2800173
- Source notice type
- Award Notice
- Solicitation number
- SPE2D222R0117
- Agency
- DEPT OF DEFENSE
- Office
- DLA TROOP SUPPORT
- Posted
- 2026-01-27 10:58:02 (source timezone unspecified)
- Response deadline (source text)
- Unavailable
- Place of performance
- Ontario, Canada, CAN
- NAICS
- 325412
- PSC
- 6505
- Set-aside
- Unavailable
- Catalog category
- defense
- Winning company / recipient
- Not asserted
- Award amount
- Unavailable — not asserted by this notice projection
- Source record updated
- 2026-10-08T19:34:51.338Z
- Latest completed catalog synchronization
- 2026-10-31T17:26:44.483Z
- Source SHA-256
- 567acffc32a11d455be77641f9e322d8e0375a7c0a2d7346d8f6e63c6efcad9a
Modification SPE2D223D0007 P00008 to exercise Option Year 3 effective February 15, 2026 through February 14, 2027. Modification SPE2D223D0007 P00007 is modified in accordance with DoD Class Deviation 2025-O0003. Modification SPE2D223D0007 P00006 to exercise Option Year 2 effective February 15, 2025 through February 14, 2026. Modification SPE2D223D0007 P00005 to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders language into solicitation for subject contract. Modification SPE2D223D0007 P00004 to exercise Option Year 1 effective February 15, 2024 through February 14, 2025. Modification SPE2D223D0007 P00003 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D223D0007 P00002 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract. Modification P00001 SPE2D2-23-D-0007 revising the the price effective date and ship date from April 16, 2023 to February 28, 2023. Contract Award for Olopatadine HCL 0.1% Opthtalmic Solution 5ML Bottle
What this source notice establishes
The label describes explicit language in the synchronized official notice. A protest-related notice does not establish a GAO ruling, protest disposition or procurement violation. Follow-on or recompete language is not independent confirmation of an approved future procurement.
No winning company, loss by a particular company, transaction obligation or total contract value is inferred from the title or narrative. Silence, expiration, cancellation and another company’s award are not treated as a company loss.
This is a dated reference, not a claim that a notice was posted today. Removal from the active opportunity feed does not itself withdraw a historical notice. STN rechecks the latest completed stored source snapshot for this notice, including corrections and withholding decisions, before serving this page. Unavailable evidence is not replaced by a demonstration record.
| SAM.gov notice ID | Source classification | Posted | Agency | Solicitation |
|---|---|---|---|---|
| 172ef8534f7745e6b7958d9ad2800173 | Award notice | 2026-01-27 10:58:02 (source timezone unspecified) | DEPT OF DEFENSE | SPE2D222R0117 |
Related information and sources
Attribution: Original public notice: SAM.gov. Source-notice classification is distinct from a verified company award or legal outcome.
The interactive STN application appears here when JavaScript is available. Published facts and source links above remain readable without JavaScript.